US 7994166
Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels for the treatment of pain
granted A61PA61P1/04A61P19/02
Quick answer
US patent 7994166 (Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels for the treatment of pain) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P1/04, A61P19/02, A61P25/00, A61P25/04